Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: the Cache County Dementia Progression Study.
Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: the Cache County Dementia Progression Study.
复制标题
DOI:
10.1176/appi.ajp.2014.14040480
复制
发表时间:
2015-05
期刊:
影响因子:
--
通讯作者:
Lyketsos CG
中科院分区:
文献类型:
--
作者:
Peters ME;Schwartz S;Han D;Rabins PV;Steinberg M;Tschanz JT;Lyketsos CG
Little is known about factors influencing the rate of progression of Alzheimer’s dementia. Using data from the Cache County Dementia Progression Study, we examined the link between clinically significant neuropsychiatric symptoms in mild Alzheimer’s dementia and progression to severe dementia or death. The Cache County Dementia Progression Study is a longitudinal study of dementia progression in incident cases of the condition. Survival analyses included unadjusted Kaplan-Meier plots and multivariate Cox proportional hazard models. Hazard ratio estimates controlled for age of dementia onset, dementia duration at baseline, gender, education level, General Medical Health Rating, and apolipoprotein E epsilon 4 (APOE-ε4) genotype. Three hundred thirty-five patients with incident Alzheimer’s dementia were studied. Sixty-eight (20%) developed severe dementia over the follow-up. Psychosis (hazard ratio=2.007, p=0.028), agitation/aggression (hazard ratio=2.946, p=0.004), and any one clinically significant neuropsychiatric symptom (domain score of ≥4, hazard ratio=2.682, p=0.001) were associated with more rapid progression to severe dementia. Psychosis (hazard ratio=1.537, p=0.011), affective symptoms (hazard ratio=1.510, p=0.003), agitation/aggression (hazard ratio=1.942, p=0.004), mildly symptomatic neuropsychiatric symptoms (domain score of 1–3, hazard ratio=1.448, p=0.024), and clinically significant neuropsychiatric symptoms (hazard ratio=1.951, p=<0.001) were associated with earlier death. Specific neuropsychiatric symptoms are associated with shorter survival time from mild Alzheimer’s dementia to severe dementia and/or death. The treatment of specific neuropsychiatric symptoms in mild Alzheimer’s dementia should be examined for its potential to delay time to severe dementia or death.
登录
查看更多内容
影响因子:
17.7
作者:
Steinberg, Martin;Lyketsos, Constantine G.
通讯作者:
Lyketsos, Constantine G.
影响因子:
9.9
作者:
Storandt, M;Grant, EA;Morris, JC
通讯作者:
Morris, JC
影响因子:
9.9
作者:
MCKHANN, G;DRACHMAN, D;STADLAN, EM
通讯作者:
STADLAN, EM
影响因子:
4.8
作者:
FOLSTEIN, MF;FOLSTEIN, SE;MCHUGH, PR
通讯作者:
MCHUGH, PR
DOI:
10.1111/j.1532-5415.1999.tb07245.x
发表时间:
1999-04-01
影响因子:
6.3
作者:
Lyketsos, CG;Galik, E;Brandt, J
通讯作者:
Brandt, J